NeuroBo Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q3 2016 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q3 2016 to Q2 2024.
  • NeuroBo Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 9, 2024 was 8.46M shares, a 78% decline year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 8.46M -30M -78% Aug 9, 2024 10-Q 2024-08-14
Q1 2024 4.91M -22.3M -81.9% Mar 25, 2024 10-K 2024-03-28
Q3 2023 38.8M +32.3M +497% Nov 9, 2023 10-Q 2023-11-13
Q2 2023 38.4M +11.8M +44.1% Aug 4, 2023 10-Q 2023-08-09
Q1 2023 27.2M +515K +1.93% Mar 24, 2023 10-K 2023-03-30
Q3 2022 6.5M -20.1M -75.5% Nov 11, 2022 10-Q 2022-11-14
Q2 2022 26.7M +4.38M +19.6% Aug 11, 2022 10-Q 2022-08-12
Q1 2022 26.7M +4.49M +20.3% Mar 25, 2022 10-K 2022-03-31
Q3 2021 26.6M +10.2M +61.9% Nov 11, 2021 10-Q 2021-11-15
Q2 2021 22.3M +5.86M +35.7% Aug 12, 2021 10-Q 2021-08-16
Q1 2021 22.2M +6.49M +41.4% Apr 9, 2021 10-K 2021-04-15
Q3 2020 16.4M +1.55M +10.5% Nov 6, 2020 10-Q 2020-11-13
Q2 2020 16.4M +1.55M +10.5% Aug 11, 2020 10-Q 2020-08-11
Q1 2020 15.7M +1.41M +9.9% Mar 23, 2020 10-K 2020-03-30
Q3 2019 14.9M +607K +4.26% Nov 6, 2019 10-Q 2019-11-08
Q2 2019 14.9M +607K +4.26% Aug 6, 2019 10-Q 2019-08-09
Q1 2019 14.3M +39.5K +0.28% Mar 11, 2019 10-K 2019-03-18
Q3 2018 14.3M +3.63M +34.2% Nov 5, 2018 10-Q 2018-11-08
Q2 2018 14.3M +3.64M +34.2% Aug 7, 2018 10-Q 2018-08-14
Q1 2018 14.2M +4.95M +53.4% Mar 7, 2018 10-K 2018-03-20
Q3 2017 10.6M +1.36M +14.7% Nov 7, 2017 10-Q 2017-11-13
Q2 2017 10.6M Aug 7, 2017 10-Q 2017-08-14
Q1 2017 9.27M Mar 3, 2017 10-K 2017-03-21
Q3 2016 9.27M Sep 9, 2016 10-Q 2016-09-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.